https://idataresearch.com/wp-content/uploads/2016/04/ReportIcon-Diabetes-MC.jpg

Insulin Pumps Market Analysis | 2019-2025 | MedCore

  • Year: 2019
  • Scope: 2015-2025
  • Region: Europe, United States
  • Pages: 140
  • Published Date: 06/02/2019
  • Type: MedCore

About MedCore Research

Our analysts meticulously research for up to 3 to 4 months to put together one suite of reports (MedSuite), which is a comprehensive analysis of a group of healthcare markets. MedCore research is one portion of that analysis that focuses on one market segment and provides further detailed segmentation to get a much more granular set of market data.

Data Types Included

  • Unit Sales, Average Selling Prices, Market Value & Growth Trends
  • 10 Year Scope (3 Year Historical + 7 Year Forecast Period)
  • Market Drivers & Limiters for Each Segment
  • Competitive Analysis with Market Shares
  • Product Portfolios

Competitive Landscape

The global insulin pump market is dominated by 3 major players, Medtronic, Insulet, and Roche.

In the U.S. and Europe insulin pump markets, the leading competitor is Medtronic. The company holds the dominant position in the durable insulin pump market, primarily attributed to a large installed base. Medtronic’s MiniMed® 670G, a hybrid closed-loop system, received CE Mark approval in June 2018 and was successfully launched in select regions in autumn 2018. The MiniMed® 670G is an integrated CGM pump that automatically adjusts basal insulin delivery based on glucose readings measured every five minutes.

 

In the United States, the second major player is Insulet, which is attributed to its monopolistic position in the patch insulin pump market. The company offers the Omnipod® System, which consists of a wearable, tubeless and wireless pod that delivers insulin, and a personal diabetes manager (PDM) that can be programmed to personalize insulin delivery. Insulin pods are attached to the body via an adhesive and are typically worn for three days before disposal. The PDM is used to initiate insulin infusion, calculate suggested insulin doses and test blood glucose levels.

 

In the European insulin pump market, the second-leading competitor is Roche. The company currently offers the Accu-Check® Insight and Accu-Check® Combo durable pumps. Accu-Check® Insight features a pre-filled insulin cartridge and is designed for patients with very low basal insulin requirements. Accu-Check® Combo features a traditional insulin reservoir and is designed for patients that require a large volume of insulin per day. Roche’s Accu-Check® Solo, a patch pump, received CE Mark approval in July 2018 and had a limited commercial launch in Austria, Poland, Switzerland, and the United Kingdom.

Industry Trends

The vast majority of the total insulin pump market value is occupied by the durable pump segment. Durable pumps account for such a large portion of the market because they are significantly more established than patch pumps and simple pumps, which were launched in the U.S. in 2005 and 2012, respectively. It is expected that durable pumps will maintain their dominance over the forecast period, despite the growing market share of patch pumps and simple pumps. Although Medtronic and Tandem hold a duopoly in the U.S. market as of 2018, SOOIL and other competitors are expected to enter the market over the forecast period.

The second-largest segment is the patch pump market, which accounts for a notable portion of the total market value. Patch pumps are an attractive therapy option for the patient demographic that values the wireless features and significant cost savings on the initial investment of the device, relative to durable pumps. Although Insulet holds a monopoly in the U.S. market as of 2018, Cellnovo and other competitors are expected to launch patch pump products over the forecast period.

Detailed Market Segmentation

All Companies Analyzed in this Study

  • Cellnovo
  • Insulet
  • Medtronic
  • Roche
  • Tandem
  • Valeritas
  • ViCentra
  • Ypsomed

 

This MedCore is also found in the full report suite titled U.S. Market Report Suite for the Diabetes Market – MedSuite

TABLE OF CONTENTS

LIST OF FIGURES IVLIST OF CHARTS VIEXECUTIVE SUMMARY 1U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW 1COMPETITIVE ANALYSIS 4MARKET TRENDS 7MARKET DEVELOPMENTS 9

PROCEDURE NUMBERS

PROCEDURE CODES INVESTIGATED 10MARKETS INCLUDED 11KEY REPORT UPDATES 13VERSION HISTORY 13

RESEARCH METHODOLOGY

1.1 RESEARCH SCOPE 141.2 IDATA'S 9-STEP METHODOLOGY 14Step 1: Project Initiation & Team Selection 14Step 2: Prepare Data Systems and Perform Secondary Research 16Step 3: Preparation for Interviews & Questionnaire Design 17Step 4: Performing Primary Research 18Step 5: Research Analysis: Establishing Baseline Estimates 20Step 6: Market Forecast and Analysis 21Step 7: Identify Strategic Opportunities 23Step 8: Final Review and Market Release 24Step 9: Customer Feedback and Market Monitoring 25

DISEASE OVERVIEW 26

2.1 INTRODUCTION 262.1.1 Types of Diabetes 262.1.2 Diabetes Complications 282.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes 302.1.4 Signs and Symptoms 312.1.5 Diabetes Monitoring 332.1.6 Treatment 352.1.7 Drug Delivery Systems 36

INSULIN PUMP MARKET

3.1 INTRODUCTION 383.1.1 Traditional Insulin Pumps 383.1.2 Patch Insulin Pumps 383.1.3 Simple Insulin Pumps 393.2 MARKET OVERVIEW 403.3 MARKET ANALYSIS AND FORECAST 443.3.1 Total Traditional Insulin Pump Market 443.3.1.1 Traditional Pump Market 483.3.1.2 Infusion Set Market 503.3.1.3 Pump Reservoir Market 523.3.2 Total Patch Insulin Pump Market 543.3.2.1 Patch Pump System Market 583.3.2.2 Insulin Pod Market 603.3.3 Simple Insulin Pump Market 623.4 DRIVERS AND LIMITERS 653.4.1 Market Drivers 653.4.2 Market Limiters 673.5 COMPETITIVE MARKET SHARE ANALYSIS 69ABBREVIATIONS 73
Chart 1.1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 - 2023 3Chart 1.2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013- 2023 3Chart 3.1: Insulin Pump Market by Segment, U.S., 2013 - 2023 42Chart 3.2: Insulin Pump Market Breakdown, U.S., 2016 43Chart 3 3: Insulin Pump Market Breakdown, U.S.,2023 43Chart 3.4: Total Traditional Insulin Pump Market by Segment, U.S., 2013 - 2023 46Chart 3.5: Total Traditional Insulin Pump Market Breakdown, U.S., 2016 47Chart 3.6: Total Traditional Insulin Pump Market Breakdown, U.S., 2023 47Chart 3.7: Traditional Pump Market, U.S., 2013 - 2023 49Chart 3.8: Infusion Set Market, U.S., 2013 - 2023 51Chart 3.9: Pump Reservoir Market, U.S., 2013 - 2023 53Chart 3.10: Total Patch Insulin Pump Market by Segment, U.S., 2013 - 2023 56Chart 3.11: Total Patch Insulin Pump Market Breakdown, U.S., 2016 57Chart 3.12: Total Patch Insulin Pump Market Breakdown, U.S.,2023 57Chart 3.13: Patch Pump System Market, U.S., 2013 - 2023 59Chart 3.14: Insulin Pod Market, U.S., 2013 - 2023 61Chart 3.15: Simple Insulin Pump Market, U.S., 2013 - 2023 64Chart 3.16: Leading Competitors, Insulin Pump Market, U.S., 2016 72
Figure 1.1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (1 of 2) 4Figure 1.2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (2 of 2) 5Figure 1.3: Companies Researched in this Report, U.S., 2016 6Figure 1.4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (1 of 2) 7Figure 1.5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (2 of 2) 8Figure 1.6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 - 2016 9Figure 1.7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 10Figure 1.8: Procedure Codes Investigated, U.S., 2016 10Figure 1.9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (1 of 2) 11Figure 1.10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (2 of 2) 12Figure 1.11: Key Report Updates 13Figure 1.12: Version History 13Figure 2.1: Major Types of Diabetes and Related Pathologies, U.S., 2016 27Figure 2.2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016 31Figure 2.3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016 32Figure 3.1: Insulin Pump Market by Segment, U.S., 2013 - 2023 (US$M) 41Figure 3.2: Total Traditional Insulin Pump Market by Segment, U.S., 2013 - 2023 (US$M) 45Figure 3.3: Traditional Pump Market, U.S., 2013 - 2023 48Figure 3.4: Infusion Set Market, U.S., 2013 - 2023 50Figure 3.5: Pump Reservoir Market, U.S., 2013 - 2023 52Figure 3.6: Total Patch Insulin Pump Market by Segment, U.S., 2013 - 2023 (US$M) 55Figure 3.7: Patch Pump System Market, U.S., 2013 - 2023 58Figure 3.8: Insulin Pod Market, U.S., 2013 - 2023 60Figure 3.9: Simple Insulin Pump Market, U.S., 2013 - 2023 63Figure 3.10: Drivers and Limiters, Insulin Pump Market, U.S., 2016 68Figure 3.11: Leading Competitors, Insulin Pump Market, U.S., 2016 71

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology